Neo Ivy Capital Management’s Carter's CRI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-6,932
Closed -$479K 321
2023
Q3
$479K Buy
+6,932
New +$495K 0.21% 164
2022
Q4
Sell
-2,431
Closed -$159K 375
2022
Q3
$159K Buy
+2,431
New +$186K 0.42% 86
2021
Q4
Sell
-1,132
Closed -$91K 466
2021
Q3
$91K Buy
1,132
+261
+30% +$26.3K 0.1% 257
2021
Q2
$90K Buy
+871
New +$88.7K 0.09% 263
2020
Q3
Sell
-1,132
Closed -$91K 486
2020
Q2
$91K Buy
1,132
+438
+63% +$34.9K 0.1% 257
2020
Q1
$46K Buy
+694
New +$66.8K 0.07% 321
2019
Q4
Sell
-1,802
Closed -$165K 284
2019
Q3
$165K Sell
1,802
-5,574
-76% -$508K 0.11% 210
2019
Q2
$719K Buy
7,376
+2,855
+63% +$278K 0.41% 123
2019
Q1
$455K Buy
+4,521
New +$403K 0.26% 158

Other funds holding CRI

Neo Ivy Capital Management's CRI Position: Q4 2023 in Review

Neo Ivy Capital Management sold out of Carter's (CRI) in Q4 2023, closing a stake of 6,932 shares — an estimated $479K sold.

Neo Ivy Capital Management first reported a position in CRI in Q1 2019 and held it in 9 quarters. The position peaked at $719K in Q2 2019. 320 funds tracked by Wall St. Rank hold CRI as of Q4 2023.

  • Neo Ivy Capital Management reported no remaining Carter's position as of Q4 2023 after selling out during the quarter.
  • Neo Ivy Capital Management sold 6,932 Carter's shares in Q4 2023, an estimated $479K.
  • Neo Ivy Capital Management first reported a position in Carter's in Q1 2019 and held it in 9 quarters.
  • Neo Ivy Capital Management's Carter's position peaked at $719K in Q2 2019.
  • 320 funds tracked by Wall St. Rank held Carter's as of Q4 2023.

Based on Neo Ivy Capital Management's 13F filing for Q4 2023, filed 26 Feb 2024.